NantHealth (NH) Tops Q4 EPS by 7c, Slight Miss on Revenues

Note: EPS may not be comparable

NantHealth (NASDAQ: NH) reported Q4 EPS of ($0.07), $0.07 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $22.3 million versus the consensus estimate of $23.28 million.

For earnings history and earnings-related data on NantHealth (NH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c